Catalyst Edge · Scanner · Tickers · MRK
CATALYST DOSSIER · UPDATED 2026-11-03

$MRK

pharma · convergence 8 · conviction WATCH
Convergence Score
8
Conviction
WATCH
Signals Firing
13
Track Record
4/8
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $MRK?

MRK 8 WATCH pharma

Quantitative

  • Revenue (CY2026Q2): $16.61B (+5.1% YoY)
  • Net Income (CY2026Q2): $-1.33B (-130.2% YoY)

Catalysts

  • Deal terms: milestone_payment 2026-10-29
  • Clinical trial milestone: MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
  • Clinical trial milestone: A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)

Risks

  • Hard-to-borrow / FTD risk: Borrow rate 6.0%, distress score 30

Bear case

  • Squeeze unwind: Short interest can compress before retail catches the move — entry timing critical

Sympathy basket (cerebro)

  • PFE via pharma r=+0.00 intra-sector (score 29)
  • AMGN via pharma r=+0.00 intra-sector (score 26)
  • BMY via pharma r=+0.00 intra-sector (score 12)
  • ABBV via pharma r=+0.00 intra-sector (score 11)
  • IBB via pharma r=+0.00 intra-sector (score 9)
  • XBI via pharma r=+0.00 intra-sector (score 9)

Signals Firing

finra_shortclinicalmacroorphan_leancongressoge_execcontractbiotechsec_fdaauto_macro_adp_payrollsauto_macro_durable_goodsauto_macro_fx_ratesauto_macro_treasury_fiscal
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Pick Track Record

DateListNext-day max runNext-day closeHit +2%?
2026-10-19sec_top_gappers+4.0%+3.3%✓ hit
2026-10-19sec_top_moat_emerging+4.0%+3.3%✓ hit
2026-10-16sec_top_gappers+1.0%-1.6%—
2026-10-16sec_top_moat_emerging+1.0%-1.6%—
2026-10-15sec_top_gappers+1.8%+0.5%—
2026-10-15sec_top_moat_emerging+1.8%+0.5%—
2026-10-13sec_top_gappers+4.4%+3.8%✓ hit
2026-10-13sec_top_moat_emerging+4.4%+3.8%✓ hit
Lifetime: 4/8 wins · hit-rate 50.0% on +2% intraday

Sympathy Basket

Tickers Catalyst Edge tracks as moving with this name. Cross-correlation derived from sector + score-cohort proximity.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

You came here for MRK. You found it after it moved, the same way everyone else did.

$99 once — every ticker on this site ranked before the open.

Tier 1 setups touched +2% intraday 44.0% of the time across 414 tracked calls. Baseline for everything else: 38.4%. That is a +5.6 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/

  1. Click Become a Founding Member below.
  2. Pay $99 once — not monthly, not ever again.
  3. You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.

30 of 30 founding seats left. The price goes up when they are gone.

Become a Founding Member — $99 once

One payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →